PROVIDER PORTAL

Publications

Publications

GDF-15, Pentraxin-3 and TIMP-1 Plasma Biomarkers Improve Risk Assessment for Mortality in Ambulatory Veterans with COPD, Masters, B., Urdaneta, G., Vital, I. A., Campos, M. A., Miller, M., and Herrera, J. E., American Journal of Respiratory and Critical Care Medicine, 2020, 201:A2856.

Plasma GDF-15 Levels Improve Risk Assessments for Severe COPD Outcomes, Masters, B., Curtis, J. L., Han, M. K., Martinez, F. J., O'Neal, W. K., Freeman, C. M., Criner, G. J., Dransfield, M. T., Bowler, R. P., Couper, D., Labaki, W. W., Hansel, N. N., Peters, S. P., Woodruff, P., Bhatt, S. P., Siler, T. M., Miller, M., and Herrera, J. E., American Journal of Respiratory and Critical Care Medicine, 2020, 201:A2860.

Raffield, L., Dang, H., Pratte, K., Jacobson, S., Gillenwater, L., Ampleford, E., Barjaktarevic, I., Basta, P., Clish, C., Comellas, A., Cornell, E., Curtis, J., Doerschuk, C., Durda, P., Emson, C., Freeman, C., Guo, X., Hastie, A., Herrera, J., Johnson, C., Labaki, W., Liu, L., Masters, B., Miller, M., Ortega, V., Papanicolaou, G., Peters, S., Taylor, K., Rich, S., Rotter, J., Auer, P., Reiner, A., Tracy, R., Nogo, D., Gerszten, R., O’Neal, W., Bowler, R., NHLBI Trans-Omics for Precision Medicine Consortium, Comparison of Proteomic Biomarker Assessment Methods in Multiple Cohort Studies, Proteomics and Systems Biology, Vol. 20, Issue 12, June 2020.

Formiga, M., Vital, I., Urdaneta, G., Masters, B., Herrera, J., Campos. M., Cahalin, L., Higher serum levels of systemic inflammatory markers are linked to greater inspiratory muscle dysfunction in copd. Clin Respir J. 2019 Feb 18.

Masters, B., Han, M., Martinez, F., Criner, G., Woodruff, P., Peters, S., Hansel, N., Comellas, A., Curtis, J., Paine, R., O’Neal, W., Herrera, J., Copeland, K., Blood biomarker algorithms as an aide to describe exacerbations activity in symptomatic smokers and early staged COPD patients. American journal of respiratory and critical care medicine 2018;197: A2747

Masters, B., Campos, M., Urdaneta, G., Vital, I., Balestrini, K., Herrera, J., Miller, M., Haney, D., Forest algorithms based upon blood biomarkers as an aide in phenotyping the COPD frequent severe exacerbator. American journal of respiratory and critical care medicine 2018;197: A2748

Masters, B., Bhatt, S., Criner, G., Martinez, M., Siler, T., Herrera, J., Latterich, M., Miller, M., Copeland, K., Hesterberg L., Blood biomarker algorithms to guide COPD assessment and risk stratification. European Respiratory Journal 2017 50: OA505

Masters, B., Bhatt, S., Criner, G., Martinez, M., Siler, T., Herrera, J., Latterich, M., Miller, M., Copeland, K., Hesterberg L., Blood biomarker algorithms to guide COPD assessment and risk stratification. European Respiratory Journal 2017 50: OA505

Balestrini, K., Guerrero, A., Schweitzer, M., Masters , B., Latterich, M., Luna Diaz, L., Escobar, L., Bagley, V., Mirsaeidi, M., Holt, G., Calderon, R., Campos , M., Evaluation of Systemic RANTES/CCL5 as a Possible Biomarker in Stable COPD Subjects. American Journal of Respiratory and Critical Care Medicine, 2017; 195: A5251.

To learn more about ProterixBio: